Investor Relations

Investor Relations

Interim Report
January – March 2022

Continued growth in sales, improved profitability and focus on commercial synergies.

BICO by Numbers

  • Net sales Q1 2022
    0 MSEK
  • Organic growth Q1 2022
    0 %
  • Employees
    0 +
  • Instruments in the field
    0 +
  • Publications
    0 +
  • Countries
    0 +

News

Thursday December 16, 2021

Investor Call recordnings

Thursday December 16, 2021

BICO acquires Biosero

Financial Reports

Calendar

05/18/22Interim report January-March 2022
08/24/22Interim report January-June 2022
11/09/22Interim report January-September 2022
02/22/23Year-end report 2022

Calendar

05/18/22Interim report January-March 2022
08/24/22Interim report January-June 2022
11/09/22Interim report January-September 2022